In cervical cancer, miR-146a also has an increased level and a tumor-promoting role, which it exerts by inhibiting IRAK1 and TRAF-6 (TNF-receptor-associated factor 6) and stimulating Cyclin-D1 [13]. The gene discussed is TRAF6; the disease is neoplasm.